Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Synthesis method of semaglutide

A technology of semaglutide and a synthesis method, which is applied in the field of peptide synthesis and preparation, can solve the problems of unfavorable environmental protection, high cost, difficult coupling and the like

Active Publication Date: 2017-05-31
SINOPEP ALLSINO BIOPHARMACEUTICAL CO LTD
View PDF4 Cites 46 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This patent reports a method for direct solid-phase synthesis of semaglutide, however, due to Lys[[N6-[N-(17-carboxy(R3)-1-oxoheptadecyl-L-γ-glutamyl[2-( The existence of 2-aminoethoxy)ethoxy] acetyl[2-(2-aminoethoxy) ethoxy]acetyl] ] group makes it very difficult to couple subsequent amino acids, often resulting in incomplete coupling, missing peptides, and a large number of miscellaneous peptides Produced, the impurities produced by such a process are difficult to remove
The existing synthesis method of semaglutide has the disadvantages of cumbersome operation, multi-step purification, long synthesis cycle, large waste liquid, unfavorable for environmental protection, large amount of acetonitrile, high cost and unfavorable for large-scale production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method of semaglutide
  • Synthesis method of semaglutide
  • Synthesis method of semaglutide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0074] Embodiment 1, a kind of synthetic method of semaglutide, comprises the following steps:

[0075] A. The fragments are condensed into various semaglutide intermediates, and the amino acid protecting groups are endowed with the following types:

[0076] (1) R-His(R1)-Ala-Glu(R2)-Gly-Thr(R4)-Phe-Thr(R4)-Ser(R4)-Asp(R5)-Val-Ser(R4)-Ser( Synthesis of R4)-Tyr(R4)-Leu-Glu(R2)-Gly-R3;

[0077] (2) Fmoc-Lys[[N6-[N-(17-carboxy(R3)-1-oxoheptadecyl-L-γ-glutamyl[2-(2-aminoethoxy)ethoxy]acetyl[2-(2-aminoethoxy)ethoxy Synthesis of ]acetyl] ]-OH;

[0078] (3) R-Gln-Ala-Ala-N6-[N-(17-carboxy(R3)-1-oxoheptadecyl-L-γ-glutamyl[2-(2-aminoethoxy)ethoxy]acetyl[2-(2- Synthesis of aminoethoxy)ethoxy]acetyl]-Lys-Glu(R2)-Phe-R3;

[0079] (4) Synthesis of R-Ile-Ala-Trp(R6)-Leu-Val-Arg(R7)-Gly-Arg(R7)-Gly-R3;

[0080](5) R-Gln-Ala-Ala-N6-[N-(17-carboxy(R3)-1-oxoheptadecyl-L-γ-glutamyl[2-(2-aminoethoxy)ethoxy]acetyl[2-(2- Synthesis of aminoethoxy)ethoxy]acetyl]-Lys-Glu(R2)-Phe-Ile-Ala-Trp(R6)-...

Embodiment 2

[0094] Example 2, in the synthesis method of semaglutide described in Example 1: the coupling system used in the synthesis of the 6 polypeptide fragments in step A is selected from:

[0095] Single condensing agent: DIC, DCC, EDC, chloroacetyl chloride, azide, TBTU, PyBOP, HBTU, HATU;

[0096] Two-system condensing agent: DIC / HOBT, DCC / HOBT, EDC / HOBT.

Embodiment 3

[0097] Example 3, in the synthesis method of semaglutide described in Example 1 or 2: the crude semaglutide is processed by purification and freeze-drying methods to obtain the semaglutide product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a synthesis method of semaglutide. According to the method, a semaglutide product is synthesized by adopting a solid-liquid phase combination method, and three fragments are simultaneously synthesized in a synthesis manner of 16+6+9 fragments, and therefore, the synthesis time of the product is greatly shortened; moreover, by step-by-step analysis on synthesis factors of His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly, Gln-Ala-Ala-N6-[N-(17-carboxy-1-oxoheptadecyl-L-gama-glutamyl [2-(2-aminoethoxy) ethoxy] acetyl [2-(2-aminoethoxy) ethoxy] acetyl]-Lys-Glu-Phe, Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH and the like, the difficulty in synthesis of a peptide sequence in solid-phase synthesis is reduced, the problem of batch amplification in the solid-phase synthesis is solved, and the synthesis efficiency is improved; and as liquid-phase fragment synthesis is adopted, the purification difficulty is effectively reduced, and the production cost is greatly lowered. The synthesis method disclosed by the invention has the advantages that the synthesis time can be shortened by 40%, the cost of materials is lowered, the generation quantities of deletion peptide and hybrid peptide are decreased, and the synthesis method is suitable for industrial large-scale production.

Description

technical field [0001] The invention belongs to the field of polypeptide synthesis and preparation, and in particular relates to a synthesis and preparation method of semaglutide. [0002] technical background [0003] Semaglutide is a new type of diabetes drug that Novo Nordisk is carrying out phase III clinical trials. It is injected once a week at a dose of 1.0 mg. Clinical trials have achieved certain results. If the oral preparation of semaglutide is successfully developed, it will greatly improve the quality of life of diabetic patients. [0004] At present, there is only one document reporting the synthesis method of this product, PCT Int. Appl., 2015055801, 23Apr 2015 (US20150111826). This patent reports a method for direct solid-phase synthesis of semaglutide, however, due to Lys[[N6-[N-(17-carboxy(R3)-1-oxoheptadecyl-L-γ-glutamyl[2-( The existence of 2-aminoethoxy)ethoxy] acetyl[2-(2-aminoethoxy) ethoxy]acetyl] ] group makes it very difficult to couple subsequent ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/605C07K1/06C07K1/04C07K1/02
CPCC07K14/605Y02P20/55
Inventor 徐峰谷海涛王小涛苏军孙美禄
Owner SINOPEP ALLSINO BIOPHARMACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com